LSE company dividends information has been updated. You can find this is in the menu on any Quote page. ADVFN team.


Kooth Plc

0.00 (0.0%)
Share Name Share Symbol Market Type Share ISIN Share Description
Kooth Plc LSE:KOO London Ordinary Share GB00BMCZLK30 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 247.00 0.00 08:00:00
Bid Price Offer Price High Price Low Price Open Price
244.00 250.00 247.00 247.00 247.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Spec Outpatient Facility,nec 20.12 -0.72 -2.20 - 81.65
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 247.00 GBX

Kooth (KOO) Latest News

Kooth (KOO) Discussions and Chat

Kooth Forums and Chat

Date Time Title Posts
02/5/202310:09Kooth-Looking for some healthy growth. 84

Add a New Thread

Kooth (KOO) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2023-06-01 16:15:00244.6610,00024,466.00O
2023-06-01 15:35:01250.0012.50O
2023-06-01 15:28:02247.451,5003,711.75O
2023-06-01 15:28:02247.451,5003,711.75O

Kooth (KOO) Top Chat Posts

Top Posts
Posted at 27/4/2023 10:48 by acuere
And then a loose lipped sports agent telling us this


"Excited about this upcoming campaign with Lane Johnson of the Philadelphia Eagles and Kooth Digital Health (North America). Kooth, a leading digital mental health platform is on a mission to provide accessible and safe spaces for youth to achieve better mental health.

Starting next month, the campaign will go live to hundreds of thousands of youth across Pennsylvania, letting them know that Kooth is there for them when it matters, and that no issue is too big or too small."


The pilot study is for 150,000 pupils. The 500 school district extension would cover 1.5m pupils. Kooth received $20 per head in the pilot study. At same rate that would translate to $30m p.a.
Fingers crossed they’ve pulled this off.

Posted at 27/4/2023 10:39 by acuere
And then the signing of an ambassador


“We are delighted that Lane is joining us as our new ambassador," said Kevin Winters, General Manager at Kooth. “At Kooth, we believe it is essential that young people have access to quality, stigma-free mental health services, so they are able to receive help quickly and when they need it most. Lane is admired by so many in the area, and for him to share our mission will go a long way to spreading the word about the service."

The partnership between Kooth and Lane Johnson represents an important step forward in breaking down stigma around mental health and providing more resources for young people in Pennsylvania. With his involvement in this initiative, Johnson hopes he can make an impact on the lives of many children facing similar issues he experienced himself.

Posted at 18/4/2023 13:47 by rimau1
They were very clear yesterday in both the Edison results call and the IM presentation. Priority is executing Cali with a 1 Jan 2024 go live. I am looking at existing next year at £40m ARR with no further contract wins so a valuation of £130m. Target price £4.00
Posted at 18/4/2023 12:28 by acuere
Yes ‘twas good. I’m still unsure if they’re trying for these other States or focussing on getting Cali right. I’d be happy for them to do placing if it meant them being able to win other States.
California is biggest state and Penn comes in at 5, but the other 3 mentioned (NY,NC,Va) are all biggies as well.

1 California 38,915,693
2 Texas 30,500,280
3 Florida 22,661,577
4 New York 19,496,810
5 Pennsylvania 12,931,957
6 Illinois 12,477,595
7 Ohio 11,747,774
8 Georgia 11,037,723
9 North Carolina 10,832,061
10 Michigan 10,030,722
11 New Jersey 9,255,437
12 Virginia 8,709,873

The other thing I’d say is if it is even split between workstreams I would expect Koo servicing 13-25yo would command greater share. So possibly $200m over 5 years.

Posted at 22/1/2023 21:41 by rimau1
Therapists costing 3x more is solved simply by Koo charging 3x more FFS!!!! Koo also set up a local US mgt team it won’t be managed from the UK. Do you have any sensible questions?
Posted at 22/1/2023 14:38 by rimau1
Last post from me here for a while. They appear (understandably given Kooth UK performance track record) very confident that the Penn pilot will be successful and lead to a larger longer contract which will in turn lead to further state contracts. However practitioners need to be licensed in the state that they operate in so it seems to me Koo will expand state by state rather than multi state roll outs which helps keep a lid on costs and retains focus but obviously takes longer. In terms of ex UK ex US expansion KOO will licence their technology out which is an excellent strategy IMO. Bolt on acquisitions unlikely although they are constantly being approached especially by distressed assets but the KOO model is primarily organic. The other snippet was that the existing cash runway extends for 2 years but in any case they expect to be cash flow positive within 3-6 months. Exciting times.
Posted at 19/1/2023 08:17 by rimau1
Excellent update. Very below the radar and the significant derating last year was simply due to the growth/tech stock association and unwarranted IMO. KOO are trading on 2 x historic ARR after stripping out net cash which is simply too cheap with sufficient balance sheet strength to find expansion plans. Plenty of clues in this update that the business is doing well; entrenched in the NHS, rolling out in Scotland, interestingly now providing an A&E emergency response to alleviate pressure on A&E and most importantly the US rollout which is historically the amber flag for me (as few businesses succeed in entry)is progressing well. Penn is bedding in and should result in further contract awards. Patience required but this is a high conviction long term hold for me.
Posted at 26/7/2022 07:43 by rimau1
Given the price action over the past 6 months i was expecting a nasty surprise in the TU but there were only 2 amber flags for me (1) a slow down in new business spending decisions with the reorganisation of the NHS regional structures (2) no mention of ARR which is a key metric for Kooth. I was hoping this would continue to track up towards £20m. The good news; Net cash was up (i didn’t expect that) and no sign of an equity raise. Of course they will be capex’ing everything so its not capital light but the balance sheet should be sufficient for the existing growth plans.
Posted at 20/7/2022 15:04 by hybrasil
Worth at most half the current share price. I’d say it’s pass the parcel time
Posted at 12/7/2022 10:45 by hybrasil
This in my view is massively overvalued. I think its a screaming short. Its a tech share set up by software people. Compare its number to for instance totally.

The turnover to market cap ratio is daft in this market.

Kooth share price data is direct from the London Stock Exchange
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |

V: D: 20230602 14:56:29